This journal is a member of the Committee on Publication Ethics (COPE).
Molecular Pain is a peer-reviewed, open access journal that considers manuscripts in pain research at the cellular, subcellular and molecular levels. Molecular Pain provides a forum for molecular pain scientists to communicate their research findings in a targeted manner to others in this important and growing field.
The field of molecular pain research has been rapidly expanding in recent years, and has great promise for the identification of highly specific and effective targets for the treatment of intractable pain.
Molecular pain research addresses physiological and pathological pain at all levels whilst integrating pain research with molecular biology, genomics, proteomics, modern electrophysiology and neurobiology.
Although several existing journals publish articles on classical pain research, none are specifically dedicated to molecular aspects of the field.
|Michael Caterina||Johns Hopkins University, USA|
|Fusao Kato||Jikei University School of Medicine, Japan|
|Amy MacDermott||Columbia University, USA|
|Dan McGehee||University of Chicago, USA|
|Emily England||University of Toronto, Canada|
|A. Vania Apkarian|
|Carlos Belmonte||Universidad Miguel Hernadez-CSIC, Spain|
|Man-Kyo Chung||University of Maryland, USA|
|Yves De Koninck||Laval University, Canada|
|Jennifer J. DeBerry||University of Alabama, Birmingham, USA|
|Sulayman Dib-Hajj||Yale School of Medicine, USA|
|Xinzhong Dong||Johns Hopkins School of Medicine, USA|
|Gregory Dussor||University of Texas, Dallas, USA|
|Hidemasa Furue||Hyogo College of Medicine, Japan|
|Robert Gereau||Washington University, USA|
|Peter A. Goldstein||Cornell University, USA|
|Yun Guan||Johns Hopkins School of Medicine, USA|
|Richard Harris||University of Michigan Medical School, USA|
|Li-Yen Huang||University of Texas Medical Branch at Galvestson, USA|
|Michael Jankowski||Cincinnati Children's Hospital Medical Center, USA|
|Michael Jarvis||Abbott Laboratories, USA|
|C. Justin Lee||Korea Institute of Science & Technology, Korea, South, South Korea|
|Koga Kohei||Hyogo College of Medicine, Japan|
|Rohini Kuner||University of Heidelberg, Germany|
|Jon Levine||University of California San Francisco, USA|
|Yun-Qing Li||Fourth Military Medical University, China|
|Ceng Luo||Fourth Military Medical University, China|
|Qiufu Q. Ma||Harvard Medical School, USA|
|MacDonald Christie||University of Sydney, Australia|
|Derek Molliver||University of New England, USA|
|Terumasa Nakatsuka||Kansai University of Health Sciences, Japan|
|Volker Neugebauer||University of Texas Medical Branch, USA|
|Uhtaek Oh||Brain Science Institute of KIST, Seoul, Korea|
|Zhizhong Pan||The University of Texas-MD Anderson Cancer Center, USA|
|Jeffrey C. Petruska||University of Louisville, USA|
|Louis Premkumar||Southern Illinois University School of Medicine, USA|
|Theodore Price||University of Arizona, USA|
|Lintao Qu||Johns Hopkins School of Medicine, USA|
|Matthias Ringkamp||Johns Hopkins School of Medicine, USA|
|Maione Sabatino||Universita degli Studi Della Campania, Italy|
|Juergen Sandkuehler||Medical University of Vienna, Austria|
|Brian L. Schmidt||New York University, USA|
|Philippe Seguela||McGill University, Canada|
|Bai Chuang Shyu||Institute of Biomedical Sciences, Taiwan|
|Robert E. Sorge||University of Alabama, Birmingham, AL, USA|
|Cheryl Stucky||Medical College Wisconsin, USA|
|Yuanxiang Tao||Rutgers The State University of New Jersey, USA|
|Andrew Todd||University of Glasgow, UK|
|Makoto Tominaga||Okazaki Institute for Integrative Bioscience, Japan|
|Hiroki Toyoda||Osaka University, Japan|
|Makoto Tsuda||Kyushu University, Japan|
|Hiroshi Ueda||Nagasaki University, Japan|
|Stephen Waxman||Yale University School of Medicine, USA|
|Feng Wei||East Lansing, Michigan|
|Long-Jun Wu||Rutgers University, USA|
|Guang-Yin Xu||Soochow University, China|
|Tian-Le Xu||Shanghai Jiao Tong University School of Medicine, China|
|Ipek Yalcin||Institute of Cellular and Integrative Neuroscience, France|
|Megumu Yoshimura||Kumamoto Health Science University, Japan|
|Vanna Zachariou||Icahn School of Medicine, USA|
|Hanns Ulrich Zeilhofer||University of Zurich, Switzerland|
|Ji Zhang||McGill University, Canada|
|Ming-Gao Zhao||Fourth Military Medical University, China|
|David Borsook||Harvard Medical School , USA|
|Geoffrey Burnstock||University College Medical School, UK|
|Steve Hunt||University College London, UK|
|Kazuhide Inoue||Kyushu University, Japan|
|Frank Porreca||University of Arizona Health Sciences Center, USA|
|Michael Salter||University of Toronto, Canada|
|Robert Yezierski||University of Florida, USA|
Please read the full Molecular Pain author guidelines before submitting a manuscript to the journal.
Molecular Pain accepts the following article types:
Research: reports of data from original research. We anticipate that a research article will contain 5-10 figures. Authors should try to limit the Background and Discussion sections to no more than 1000 and 1500 words respectively. Order sections as follows:
Materials and Methods
Declaration of Conflicting Interests
Review: comprehensive, authoritative descriptions of any subject within the scope of the journal. Enquiries to the Molecular Pain Editors regarding the suitability of a proposed review prior to submission are encouraged.
Commentary: short, focused and opinionated articles on any subject within the scope of the journal. These articles are usually related to a contemporary issue, such as recent research findings. Enquiries to the Molecular Pain Editors regarding the suitability of a subject area prior to submission are encouraged.
Conflicting report: brief reports of data from original research that conflict with a recent key finding published in a high-impact, broad-scope journal, such as Science, Nature and Cell. A conflicting report can be a negative result that nulls the previous key finding. The main purpose of a conflicting report is to challenge an existing finding and to provide a different and/or opposite opinion or interpretation on a dominant view. This encourages scientific debates and helps to correct potential mistakes of a major article published in a high-impact journal. For a conflicting report, authors must clearly acknowledge the previous key finding, followed by their conflicting results. The format and length of a conflicting report are similar to that of a Molecular Pain short report.
Meeting report: a short description of a conference that the author has attended, which focuses on the key developments presented and discussed at the meeting.
Methodology: present a new experimental method, test or procedure. The method described may either be completely new, or may offer a better version of an existing method.
Short report: brief reports of data from original research that present very important findings in the field. A complex figure with several panels is encouraged.
Please read the guidelines, then visit the Journal’s submission site https://mc.manuscriptcentral.com/molecularpain upload your manuscript. Please note that manuscripts not conforming to these guidelines may be returned.
If, after peer review, your manuscript is accepted for publication, a one-time Article Processing Charge (APC) is payable. This APC covers the cost of publication and ensures that your article will be freely available online in perpetuity under a Creative Commons license.
The Article Processing Charge (APC) is $2500.
Only manuscripts of sufficient quality that meet the aims and scope of Molecular Pain will be reviewed.
As part of the submission process you will be required to warrant that you are submitting your original work, that you have the rights in the work, that you are submitting the work for first publication in the Journal and that it is not being considered for publication elsewhere and has not already been published elsewhere, and that you have obtained and can supply all necessary permissions for the reproduction of any copyright works not owned by you.
Molecular Pain publishes manuscripts under Creative Commons licenses. The standard Molecular Pain license is Creative Commons by Attribution Non-Commercial (CC BY-NC), which allows others to re-use the work without permission as long as the work is properly referenced and the use is non-commercial. For more information, you are advised to visit SAGE's OA licenses page.
This Journal recommends that authors follow the Uniform Requirements for Manuscripts Submitted to Biomedical Journals formulated by the International Committee of Medical Journal Editors (ICMJE).
Egle M Mambretti, Katrin Kistner, Stefanie Mayer, Dominique Massotte, Brigitte L Kieffer, Carsten Hoffmann, Peter W Reeh, Alexander Brack, Esther Asan, and Heike L Rittner
Functional and structural characterization of axonal opioid receptors as targets for analgesia
Mol Pain January-December 2016 12: 1744806916628734, first published on March 1, 2016 doi:10.1177/1744806916628734